0000914190-16-000760.txt : 20160822 0000914190-16-000760.hdr.sgml : 20160822 20160822171152 ACCESSION NUMBER: 0000914190-16-000760 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160818 FILED AS OF DATE: 20160822 DATE AS OF CHANGE: 20160822 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kummeth Charles R. CENTRAL INDEX KEY: 0001534980 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 161845883 MAIL ADDRESS: STREET 1: 425 MARTINGALE ROAD STREET 2: SUITE 1000 CITY: SCHAUMBURG STATE: IL ZIP: 60173-2213 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-08-18 0000842023 BIO-TECHNE Corp TECH 0001534980 Kummeth Charles R. 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 1 1 0 0 Chief Executive Officer Common Stock 2016-08-18 4 A 0 16653 0 A 61030 D Stock Option (Right to Buy) 67.46 2020-04-01 Common Stock 65000 65000 D Stock Option (Right to Buy) 67.46 2020-04-01 Common Stock 50000 50000 D Stock Option (Right to Buy) 86.25 2021-04-01 Common Stock 46316 46316 D Stock Option (Right to Buy) 94.35 2021-08-12 Common Stock 80460 80460 D Restricted Stock Unit Common Stock 11129 11129 D Stock Option (Right to Buy) 108.49 2022-08-07 Common Stock 79517 79517 D Stock Option (Right to Buy) 108.49 2022-08-07 Common Stock 119275 119275 D Restricted Stock Unit Common Stock 17283 17283 D Stock Option (Right to Buy) 106.59 2016-08-18 4 A 0 102779 0 A 2023-08-18 Common Stock 102779 102779 D Stock Option (Right to Buy) 106.59 2016-08-18 4 A 0 154169 0 A 2023-08-18 Common Stock 154169 154169 D Restricted Stock Unit 2016-08-18 4 A 0 24979 0 A Common Stock 24979 24979 D Includes (i) 2,551 shares for which the risk of forfeiture will lapse with respect to 2,551 shares on April 1, 2017; (ii) 10,203 shares for which the risk of forfeiture will lapse pursuant to achievement of performance goals; (iii) 7,682 shares for which the risks of forfeiture will lapse with respect to 3,841 shares on each of August 7, 2017 and August 7, 2018; and (iv) 16,653 shares for which the risks of forfeiture will lapse with respect to 5,551 shares on each of August 18, 2017, August 18, 2018 and August 18, 2019. The option will vest pursuant to the following schedule: 8,125 shares on October 1, 2013, 1,354 shares on the first day of each month for the period beginning November 1, 2013 and ending March 1, 2017, and 1,361 shares on April 1, 2017. Fully exercisable pursuant to achievement of performance goals. The option will vest pursuant to the following schedule: 5,790 shares on October 1, 2014, 965 shares on the first day of the month for the period beginning November 1, 2014 and ending March 1, 2018, and 961 shares on April 1, 2018. Vests in full or in part if certain performance goals are achieved during each of the 2015, 2016 and 2017 fiscal years. 19,879 shares vest on each of August 7, 2016, August 7, 2017 and August 7, 2018 and 19,880 shares vest on August 7, 2019. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Vests 25,695 shares on each of 8/18/17, 8/18/18, and 8/18/19 and 25,694 shares on 8/18/20. Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). /s/ Elizabeth M. Dunshee as Attorney-in-Fact for Charles R. Kummeth pursuant to Power of Attorney previously filed. 2016-08-22